Back to search

Article

Is it necessary to prescribe the same dose to subclinical lesions as gross tumor volume in non-small-cell lung cancer? —a failure pattern analysis

2022-10-13

Abstract excerpt

<h4>Background: </h4> As the standard practice of our institution, 60Gy is prescribed to PGTV and 54Gy to PTV in the radical radiotherapy of non-small cell lung cancer (NSCLC). We estimate whether this practice could achieve similar tumor control, and protect lymphocyte at the same time. Methods Failure patterns of 46 stage III NSCLC patients received radical radio-chemotherapy were analyzed. Target delineation c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8498d88f-4ad6-5442-8f3a-9e92d7ab3091
DOI
10.21203/rs.3.rs-2146660/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Is it necessary to prescribe the same dose to subclinical lesions as gross tumor volume in non-small-cell lung cancer? —a failure pattern analysisDOI 10.21203/rs.3.rs-2146660/v1
Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes.Semantic proximity
First Measurement: Proactive Immune Cell Sparing in Radiation TherapySemantic proximity
Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutationsSemantic proximity
Clinically Validated Model Predicts the Effect of Intratumoral Heterogeneity on Overall Survival for Non-Small Cell Lung Cancer (NSCLC) PatientsSemantic proximity
Risk analysis of grade ≥ 2 radiation pneumonitis based on radiotherapy timeline in stage III/IV non-small cell lung cancer: a retrospective studySemantic proximity
Risk Prediction of Radiation-Induced Hepatic Toxicity Complications in Patients With Hepatocellular CarcinomaSemantic proximity
Preoperative chemoradiation-induced hematological toxicity and related vertebral dosimetry evaluations in patients with locally advanced gastric cancer: data from a phase III clinical trialSemantic proximity
Mean heart dose-based normal tissue complication probability model for pericardial effusionSemantic proximity
Risk Analysis of Severe Thrombocytopenia in Nasopharyngeal Carcinoma During Concurrent Radio-ChemotherapySemantic proximity
Circulating-blood dose is associated with severe lymphopenia in thoracic radiotherapy, but added simulation complexity provides no detectable incremental informationSemantic proximity
Predicting severe radiation pneumonitis in patients with locally- advanced non-small cell lung cancer after thoracic radiotherapy: Development and internal validation of a nomogram based on the clinical, hematological and dose–volume histogram parametersSemantic proximity
Stereotactic Core Ablative Radiation Therapy (SCART) - principal and practice of a novel strategy to treat bulky tumorSemantic proximity
Select a neighboring publication to make it the new centre.